C N Epperson

Author PubWeight™ 13.52^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.	Mol Psychiatry	2002	3.01
2	A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.	Arch Gen Psychiatry	2000	2.48
3	Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.	J Clin Psychiatry	1995	1.52
4	Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder.	Mol Psychiatry	1998	1.05
5	Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.	J Clin Psychiatry	1999	1.00
6	Sertraline and breast-feeding.	N Engl J Med	1997	0.89
7	Intranasal oxytocin in trichotillomania.	Biol Psychiatry	1996	0.78
8	Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.	Am J Psychiatry	1998	0.77
9	Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder.	Biol Psychiatry	1999	0.76
10	A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.	Drug Saf	1996	0.75
11	Obsessive-compulsive symptoms with-neuroleptics.	J Am Acad Child Adolesc Psychiatry	1996	0.75
12	Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.	J Clin Psychopharmacol	1998	0.75